New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Research shows why some children may be slower to learn words

Research shows why some children may be slower to learn words

by University of East AngliaCredit: Unsplash/CC0 Public DomainNew research from University of East Anglia reveals why some children may be slower to learn words than others.A study published toda
Pediatrics May 07,2024
Research shows why some children may be slower to learn words

Research shows why some children may be slower to learn words

by University of East AngliaCredit: Unsplash/CC0 Public DomainNew research from University of East Anglia reveals why some children may be slower to learn words than others.A study published toda
Pediatrics May 07,2024
Research sheds light on the virulence of Staphylococcus lugdunensis in pediatric populations

Research sheds light on the virulence of Staphylococcus lugdunensis in pediatric populations

by Cactus Communications(A) Summary of antibiotics prescribed for S. lugdunensis infection. (B) Non-flucloxacillin antibiotics prescribed. Credit:Pediatric Investigation(2022). DOI: 10.100
Pediatrics May 07,2024
Research sheds light on the virulence of Staphylococcus lugdunensis in pediatric populations

Research sheds light on the virulence of Staphylococcus lugdunensis in pediatric populations

by Cactus Communications(A) Summary of antibiotics prescribed for S. lugdunensis infection. (B) Non-flucloxacillin antibiotics prescribed. Credit:Pediatric Investigation(2022). DOI: 10.100
Pediatrics May 07,2024
A mathematical model that predicts how severe hay fever season will be

A mathematical model that predicts how severe hay fever season will be

by Bob Yirka , Medical XpressCredit: Pixabay/CC0 Public DomainAn international team of researchers has developed a mathematical model for predicting how bad an upcoming hay fever season will be. In th
Immunology & Rheumatology May 07,2024
A mathematical model that predicts how severe hay fever season will be

A mathematical model that predicts how severe hay fever season will be

by Bob Yirka , Medical XpressCredit: Pixabay/CC0 Public DomainAn international team of researchers has developed a mathematical model for predicting how bad an upcoming hay fever season will be. In th
Immunology & Rheumatology May 07,2024
A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja
Oncology May 07,2024
A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja
Oncology May 07,2024
A key gene modifies regulatory T cells to fine-tune the immune response

A key gene modifies regulatory T cells to fine-tune the immune response

by Salk InstituteA histology image showing inflammation in colon epithelium. Weakening of regulatory T cell function induces infiltration of immune cells (small blue dots) into colon epithelium (
Immunology & Rheumatology May 07,2024
A key gene modifies regulatory T cells to fine-tune the immune response

A key gene modifies regulatory T cells to fine-tune the immune response

by Salk InstituteA histology image showing inflammation in colon epithelium. Weakening of regulatory T cell function induces infiltration of immune cells (small blue dots) into colon epithelium (
Immunology & Rheumatology May 07,2024
T-cell tests unreliable in establishing previous COVID-19

T-cell tests unreliable in establishing previous COVID-19

by Uppsala UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCan T-cell tests be used to determine whet
Public Health & Prevention May 07,2024
T-cell tests unreliable in establishing previous COVID-19

T-cell tests unreliable in establishing previous COVID-19

by Uppsala UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCan T-cell tests be used to determine whet
Public Health & Prevention May 07,2024
New research connects the hormones we're born with to lifetime risk for immunological diseases

New research connects the hormones we're born with to lifetime risk for immunological diseases

by Michigan State UniversityThis research shows that it's our perinatal hormones, not our adult sex hormones, that have a greater influence on our risk of developing mast cell-associated diso
Immunology & Rheumatology May 07,2024
New research connects the hormones we're born with to lifetime risk for immunological diseases

New research connects the hormones we're born with to lifetime risk for immunological diseases

by Michigan State UniversityThis research shows that it's our perinatal hormones, not our adult sex hormones, that have a greater influence on our risk of developing mast cell-associated diso
Immunology & Rheumatology May 07,2024
T cells alone are sufficient to establish and maintain HIV infection in the brain

T cells alone are sufficient to establish and maintain HIV infection in the brain

by University of North Carolina Health CareScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDA new study by Unive
Immunology & Rheumatology May 07,2024
T cells alone are sufficient to establish and maintain HIV infection in the brain

T cells alone are sufficient to establish and maintain HIV infection in the brain

by University of North Carolina Health CareScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDA new study by Unive
Immunology & Rheumatology May 07,2024
A stealthy way to combat tumors

A stealthy way to combat tumors

by Anne Trafton,Massachusetts Institute of TechnologyMIT researchers have identified a specialized subset of dendritic cells that help stimulate T cells to attack tumors. In this image, the blue
Immunology & Rheumatology May 07,2024
A stealthy way to combat tumors

A stealthy way to combat tumors

by Anne Trafton,Massachusetts Institute of TechnologyMIT researchers have identified a specialized subset of dendritic cells that help stimulate T cells to attack tumors. In this image, the blue
Immunology & Rheumatology May 07,2024
T-cells: The superheroes in the battle against omicron

T-cells: The superheroes in the battle against omicron

by Luke O'neill,The ConversationCredit: AI-generated imageOmicron is spreading rapidly throughout the world, with experts claiming that 40% of the global population will be infected within t
Immunology & Rheumatology May 07,2024
T-cells: The superheroes in the battle against omicron

T-cells: The superheroes in the battle against omicron

by Luke O'neill,The ConversationCredit: AI-generated imageOmicron is spreading rapidly throughout the world, with experts claiming that 40% of the global population will be infected within t
Immunology & Rheumatology May 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com